High Resolution Ultrasound in Pancreatic Ductal Adenocarcinoma
Advancing The Local Staging Of Pancreatic Ductal Adenocarcinoma Through High-Resolution Ultrasound: A Pilot Study
1 other identifier
interventional
30
1 country
1
Brief Summary
Pancreatic cancer patients at UHN who have had a CT at UHN and have surgery planned will undergo a high resolution ultrasound pre-operatively and intra-operatively. This study is being done to see if using high resolution ultrasound before and during surgery will help the doctors accurately diagnose pancreatic ductal adenocarcinoma and identify if the disease has spread to other areas of the body.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2019
CompletedFirst Posted
Study publicly available on registry
January 29, 2019
CompletedStudy Start
First participant enrolled
February 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
October 10, 2024
October 1, 2024
7.8 years
January 11, 2019
October 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
High-resolution U/S will be used to measure vascular invasion and regional lymph node metastases in PDAC
The U/S results will be compared to pre-operative CT scan to help determine the diagnostic effectiveness of High Resolution US
within 2 weeks of surgery
Study Arms (1)
High Resolution Ultasound
OTHERDiagnostic high resolution ultrasound pre-operatively and intraoperatively
Interventions
High resolution ultrasound pre-operatively and intra-operatively
Eligibility Criteria
You may qualify if:
- Males and females \> 18 y
- PDAC diagnosed by typical imaging findings or pathology
- Scheduled for surgical resection
- Contrast enhanced CT scan performed locally at UHN
You may not qualify if:
- \) Inability or unwillingness to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Health Network
Toronto, Ontario, M5G 2C4, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Korosh Khalili, MD
UHN
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2019
First Posted
January 29, 2019
Study Start
February 1, 2019
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
October 10, 2024
Record last verified: 2024-10